Johnson & Johnson to Host Investor Conference Call on Third Quarter Results
NEW BRUNSWICK, N.J., Sept. 18, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15th to review third-quarter results. Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include the following executives: Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices; Thibaut Mongon, Executive Vice President, Worldwide Chairman, Consumer; and Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals.
Investors and other interested parties can access the webcast/conference call in the following ways:
The webcast and presentation material are accessible at Johnson & Johnson's website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
By telephone: for both "listen-only" participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
A replay of the conference call will be available until approximately 12:00 a.m. on October 23, 2019. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13694535.
The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.
Omeros Corporation , today announced that the company will issue its financial results for the quarter and year ended March 31, 2024, on Wednesday, May 15, 2024, after the market closes. Omeros management will host a conference call and webcast that...
VMS BioMarketing today announced that its OneVoicetm solution has been selected as winner of the "Best Patient Relationship Management Solution" award in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an...
Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, announces that it intends to...
National Physical Fitness and Sports Month is celebrated annually in May to promote the importance of staying active and maintaining a healthy lifestyle through physical activity and sports. It's a time to encourage people of all ages and abilities...
PermitUsNow proudly announces the participation of its esteemed leader, Helen Callier, in the groundbreaking ceremony for the expansion of the new Harris Health Lyndon B. Johnson Hospital campus. With hundreds of invited guests and dignitaries...
The "Cell and Gene Therapies in CNS Disorders" report has been added to ResearchAndMarkets.com's offering.
The analyst anticipates that the global CGT market value in CNS disorders will experience significant growth - sales are expected to increase...